Agilent Technologies Inc (NYSE:A) Holdings Decreased by Sector Gamma AS

Share on StockTwits

Sector Gamma AS trimmed its position in shares of Agilent Technologies Inc (NYSE:A) by 10.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 260,293 shares of the medical research company’s stock after selling 28,772 shares during the period. Agilent Technologies comprises 3.4% of Sector Gamma AS’s investment portfolio, making the stock its 10th largest position. Sector Gamma AS’s holdings in Agilent Technologies were worth $19,946,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. BlackRock Inc. increased its stake in Agilent Technologies by 0.7% in the 2nd quarter. BlackRock Inc. now owns 25,137,175 shares of the medical research company’s stock worth $1,876,994,000 after purchasing an additional 178,265 shares during the period. Vanguard Group Inc. increased its stake in Agilent Technologies by 0.7% in the 2nd quarter. Vanguard Group Inc. now owns 24,950,780 shares of the medical research company’s stock worth $1,863,074,000 after purchasing an additional 177,251 shares during the period. Invesco Ltd. increased its stake in Agilent Technologies by 478.4% in the 2nd quarter. Invesco Ltd. now owns 9,230,526 shares of the medical research company’s stock worth $689,243,000 after purchasing an additional 7,634,621 shares during the period. D. E. Shaw & Co. Inc. increased its stake in Agilent Technologies by 40.8% in the 2nd quarter. D. E. Shaw & Co. Inc. now owns 4,910,795 shares of the medical research company’s stock worth $366,689,000 after purchasing an additional 1,423,567 shares during the period. Finally, Findlay Park Partners LLP increased its stake in Agilent Technologies by 51.9% in the 2nd quarter. Findlay Park Partners LLP now owns 4,500,000 shares of the medical research company’s stock worth $336,015,000 after purchasing an additional 1,538,234 shares during the period.

Shares of A traded up $0.73 during mid-day trading on Friday, hitting $76.64. 1,157,853 shares of the company’s stock traded hands, compared to its average volume of 2,235,919. The company has a quick ratio of 1.72, a current ratio of 2.13 and a debt-to-equity ratio of 0.27. Agilent Technologies Inc has a 1 year low of $62.00 and a 1 year high of $82.27. The firm has a market capitalization of $23.38 billion, a P/E ratio of 27.47, a PEG ratio of 1.88 and a beta of 1.42. The business’s 50-day moving average price is $75.70 and its 200-day moving average price is $72.83.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, August 14th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.72 by $0.04. Agilent Technologies had a return on equity of 20.00% and a net margin of 21.06%. The firm had revenue of $1.27 billion for the quarter, compared to analysts’ expectations of $1.24 billion. During the same period in the previous year, the firm earned $0.67 earnings per share. The business’s revenue was up 5.6% compared to the same quarter last year. Sell-side analysts anticipate that Agilent Technologies Inc will post 3.08 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st were paid a dividend of $0.164 per share. The ex-dividend date was Monday, September 30th. This represents a $0.66 annualized dividend and a dividend yield of 0.86%. Agilent Technologies’s dividend payout ratio (DPR) is presently 23.66%.

In related news, CEO Michael R. Mcmullen sold 24,635 shares of Agilent Technologies stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $77.50, for a total transaction of $1,909,212.50. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Heidi Fields sold 4,000 shares of Agilent Technologies stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $78.56, for a total value of $314,240.00. Following the sale, the director now owns 53,287 shares in the company, valued at $4,186,226.72. The disclosure for this sale can be found here. Insiders have sold 32,635 shares of company stock worth $2,507,293 over the last three months.

A has been the topic of a number of analyst reports. Piper Jaffray Companies lifted their price target on Agilent Technologies from $83.00 to $86.00 and gave the stock an “overweight” rating in a research note on Thursday, August 15th. Bank of America cut Agilent Technologies from a “buy” rating to a “neutral” rating and set a $76.00 price target on the stock. in a research note on Tuesday, July 16th. Robert W. Baird reaffirmed an “outperform” rating and issued a $82.00 price target (up from $79.00) on shares of Agilent Technologies in a research note on Thursday, August 15th. UBS Group cut Agilent Technologies from a “buy” rating to a “neutral” rating and set a $82.00 price target on the stock. in a research note on Friday, October 18th. Finally, Zacks Investment Research cut Agilent Technologies from a “buy” rating to a “hold” rating and set a $75.00 price target on the stock. in a research note on Monday, August 19th. Seven investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $84.00.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Featured Story: Diversification in Investing

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

US-China Biomedical Technology  Shares Up 428.6%
US-China Biomedical Technology Shares Up 428.6%
Wonderfilm Media  Stock Price Down 6.1%
Wonderfilm Media Stock Price Down 6.1%
Insurance Acquisition  Trading Up 0.1%
Insurance Acquisition Trading Up 0.1%
Oroplata Resources  Trading 2.9% Higher
Oroplata Resources Trading 2.9% Higher
Jefferies Financial Group Analysts Raise Earnings Estimates for Easterly Government Properties Inc
Jefferies Financial Group Analysts Raise Earnings Estimates for Easterly Government Properties Inc
Equities Analysts Issue Forecasts for MONOTARO CO LTD/ADR’s FY2019 Earnings
Equities Analysts Issue Forecasts for MONOTARO CO LTD/ADR’s FY2019 Earnings


© 2006-2019 Ticker Report